In a surprising find, researchers in Finland have discovered that men who've been infected with the sexually transmitted disease chlamydia appear to have a reduced risk of developing prostate cancer, Reuters Health reports. Scientists at the National Public Health Institute in Oulu expected to see an increased risk for the cancer, based on previous studies showing that chlamydia boosts a woman's risk for cervical cancer. But a study of male blood samples taken over a 30-year period showed that men who had antibodies against chlamydia, indicating a previous infection, had a 31% lower incidence of prostate cancer than men who had never been infected with the STD. Even more unexpected was that the researchers determined that the higher the number of chlamydia antibodies in the blood, which indicate a persistent infection or multiple infections, the lower the cancer risk was. The researchers say their findings should not lead men to attempt to become infected with chlamydia to lower their cancer risk, but they note that it does open the door to antibody research for possible cancer risk-lowering treatments.
Search
AI Powered
Human content,
AI powered search.
Latest Stories
Stay up to date with the latest in LGBTQ+ news with The Advocate’s email newsletter, in your inbox five days a week.
@ 2026 Equal Entertainment LLC.
All rights reserved
All rights reserved
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
The Latest
Support Independent Journalism
LGBTQ+ stories deserve to betold.
Your membership powers The Advocate's original reporting—stories that inform, protect, and celebrate our community.
Become a Member
FOR AS LITTLE AS $5. CANCEL ANYTIME.
More For You
Most Popular
@ 2026 Equal Entertainment LLC. All Rights reserved














